Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review.
Diagnostics (Basel). 2021 May 2;11(5):824. doi: 10.3390/diagnostics11050824.
Diagnostics (Basel). 2021.
PMID: 34063278
Free PMC article.
Review.
The Potential Role of Salivary NT-proBNP in Heart Failure.
Rammos A, Bechlioulis A, Kalogeras P, Watson CJ, Salvo P, Lomonaco T, Kardakari O, Tripoliti EE, Goletsis Y, Fotiadis DI, Katsouras CS, Michalis LK, Naka KK.
Rammos A, et al. Among authors: kalogeras p.
Life (Basel). 2023 Aug 28;13(9):1818. doi: 10.3390/life13091818.
Life (Basel). 2023.
PMID: 37763222
Free PMC article.
Item in Clipboard
Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry).
Rallidis LS, Tasoulas D, Leventis I, Malkots B, Kladou E, Zapantiotis D, Theofilatos A, Zormpas G, Kalogeras P, Betsis C, Lykoudis A, Tsamoulis D, Kalantzis C, Miliotou A, Daios S, Delakis I, Manolis G, Papathanasiou KA, Vlachopoulos C.
Rallidis LS, et al. Among authors: kalogeras p.
Hellenic J Cardiol. 2022 Jul-Aug;66:84-86. doi: 10.1016/j.hjc.2022.05.008. Epub 2022 May 25.
Hellenic J Cardiol. 2022.
PMID: 35623541
Free article.
No abstract available.
Item in Clipboard
Extremely high-risk patients with acute coronary syndrome: How "extreme" should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?
Rallidis LS, Tsamoulis D, Leventis I, Kalogeras P, Delakis I, Samiotis E, Kalantzis C, Malkots B, Tasoulas D, Bouratzis V, Eleutheriou D, Daios S, Potoupni V, Zervakis S, Xygka G, Miliotou A, Papathanasiou KA, Vlachopoulos C.
Rallidis LS, et al. Among authors: kalogeras p.
Kardiol Pol. 2023;81(10):1012-1014. doi: 10.33963/KP.a2023.0147. Epub 2023 Jul 4.
Kardiol Pol. 2023.
PMID: 37401581
Free article.
No abstract available.
Item in Clipboard
Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult.
Rallidis LS, Papathanasiou KA, Tsamoulis D, Bouratzis V, Leventis I, Kalantzis C, Malkots B, Kalogeras P, Tasoulas D, Delakis I, Lykoudis A, Daios S, Potoupni V, Zervakis S, Theofilatos A, Kotrotsios G, Kostakou PM, Kostopoulos K, Gounopoulos P, Mplani V, Zacharis E, Barmpatzas N, Kotsakis A, Papadopoulos C, Trikas A, Ziakas A, Skoularigis I, Naka KK, Tziakas D, Panagiotakos D, Vlachopoulos C.
Rallidis LS, et al. Among authors: kalogeras p.
Diabetes Res Clin Pract. 2024 Apr 9;211:111664. doi: 10.1016/j.diabres.2024.111664. Online ahead of print.
Diabetes Res Clin Pract. 2024.
PMID: 38604446
Item in Clipboard
Cite
Cite